Healthcare

With the Affordable Care Act, healthcare is rapidly moving towards a new market paradigm in which the consumer is the primary economic decision maker. Payers and providers will likely spend more on new information tools focused on the healthcare consumer and driving efficiency. Biopharma and medtech companies can drive higher valuations with innovative products that deliver both better clinical outcomes and cost reduction for the industry.

ICR has partnered with more than 75 biopharma, medtech, diagnostics, services and HCIT companies. Our dedicated healthcare team includes professionals with experience as buy-side analysts, sell-side analysts, and investment bankers with direct responsibility for over $15 billion in capital markets healthcare transactions. With our extensive network of healthcare equity research analysts, institutional investors, venture capitalists and bankers, your message carries the credibility to get a favorable reception. Leveraging our healthcare industry knowledge and strategic communications expertise, we invest the resources to understand each client’s business model and competitive differentiation in order to provide strategic counsel and unmatched execution on both a pre-IPO and post-IPO basis or in raising the company’s visibility and preparing for a strategic sale.

 

‘Hype vs. Reality’ – Managing the Delicate PR Balance for Innovation-Driven Businesses

But there is a fine line running between the reality of promising innovation and overhyped expectations that PR professionals must walk when helping companies

READ MORE
 

Dual-Listed IPOs: The Keys to Success in Managing a Cross-Border Offering

There is no expected slowdown in the pace of Canadian, or TSX-listed, companies looking to list in the U.S.

READ MORE
 

Integrated Communications in the Life Sciences

One of the biggest challenges to achieving communications integration in the agency and corporate setting is culture.

READ MORE
 

Focus on Life Science and Healthcare Sectors

ICR Healthcare, a newly-branded specialty practice that provides communications counsel and support for ICR’s growing roster of clients in the biopharmaceutical, medtech and healthcare services sectors.

READ MORE

OUR PEOPLE

stephanie_carrington_01

Stephanie Carrington

Senior Vice President
david_clair_01

David Clair, CFA

Senior Vice President
mike_fox_01

Michael Fox

Managing Partner
Laura Hassebroek0005

Laura Hassebroek

Vice President
James Heins

James Heins

Senior Vice President
Eric Laub0006

Eric Laub

Senior Vice President
john_mills_01

John F. Mills

Managing Partner
Darcy Robinson0016_wp

Darcie Robinson

Account Director
Brian Wright

Brian Wright

Vice President